期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical Studies on Treatment of Acute Cerebral Infarction with Xueshuantong(血栓通)Injection 被引量:2
1
作者 杜金行 任在方 +1 位作者 史载祥 黄力 《Chinese Journal of Integrated Traditional and Western Medicine》 2003年第1期21-24,共4页
Objective: To observe the effect of Xueshuantong injection (XST,血栓通注射液) with its ingredient as Notoginseng saponin, on acute cerebral infarction (ACI) and on blood coagulation and fibri-nolysis, so as to compreh... Objective: To observe the effect of Xueshuantong injection (XST,血栓通注射液) with its ingredient as Notoginseng saponin, on acute cerebral infarction (ACI) and on blood coagulation and fibri-nolysis, so as to comprehensively analyse the mechanism of XST. Methods: Fifty ACI patients were randomly divided into 2 groups, and XST group (30 patients) was treated with XST, and the control group (20 patients) given low molecular dextrose, as well as low molecular heparin calcium. The course of treatment for both groups was 15 days. The changes of effective rate, score of neurologic impairment, tissue-type plasminogen activator (tPA), inhibitor of plasminogen activator (PAI), D-D dimmer, antithrombin-III (AT-III), and fibrinogen (Fbg) were all observed. Results: The total effective rate of XST group was 73.33%, that of the control group 65. 00%. After the therapy, plasma level of tPA, ratio of tPA/PAI, and AT-III content were increased obviously, while the plasma level of PAI and D-D dimmer were decreased significantly (all P<0.01) . But there was only insignificant difference between the 2 groups (P> 0.05).Conclusion: XST injection could be effective to ACI, the mechanism of which is probably related to improving the balance between plasminogen activator and its inhibitory factor, increasing the activity of fi-brinolysin, inactivating thrombin, inhibiting platelet aggregation induced by thrombin, and decreasing blood coagulation. 展开更多
关键词 XUESHUANTONG acute cerebral infarction tissue type plasminogen plasminogen inhibitor d-d dimmer antithrombin-III fibrinogen
下载PDF
脑梗塞患者血LP(a)、ox-LDL、D-D、Fbg含量的研究 被引量:1
2
作者 潘殿卿 陈玉生 +2 位作者 何新霞 刘桂龙 李志梅 《脑与神经疾病杂志》 1997年第3期148-151,共4页
本研究按不同年龄组分别测定了110例正常人和123例脑梗塞患者急性期和恢复期血中LP(a)、ox-LDL、D-D、Fbg的含量,结果显示:脑梗塞患者血中LP(a)、ox-LDL、D-D、Fbg较正常对照组显著升高(P<0.01),并且LP(a)、ox-LDL、D-D在... 本研究按不同年龄组分别测定了110例正常人和123例脑梗塞患者急性期和恢复期血中LP(a)、ox-LDL、D-D、Fbg的含量,结果显示:脑梗塞患者血中LP(a)、ox-LDL、D-D、Fbg较正常对照组显著升高(P<0.01),并且LP(a)、ox-LDL、D-D在脑梗塞人血中呈正相关(r=0.876,P<0.05)。正常人D-D的含量随年龄的增高有增长趋势,低年龄组与高年龄组有显著性差异(q=4.82,P<0.01)。LP(a)、OX-LDL、Fbg含量各年龄组无差异(P>0.05)。D-D随年龄增长塔高明显(R=0.596P<0.01)并且与梗塞面积正相关(r=0.819,P<0.01),而LP(a)、OX-LDL、Fbg与梗塞面积无关。同时发现D-D在脑梗塞恢复期明显降低(P<0.05),证实了脑梗塞急性期确实存在高凝状态和内源性纤溶功能活跃。 展开更多
关键词 D-=聚体(d-d) 纤维蛋白原 脑梗塞
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部